Navigation Links
Halozyme Therapeutics To Present At The BioCentury Newsmakers In The Biotech Industry Conference
Date:9/20/2013

SAN DIEGO, Sept. 20, 2013 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will be presenting at the BioCentury Newsmakers in the Biotech Industry Conference in New York on Friday, Sept. 27, 2013 at 8:30 a.m. ET/5:30 a.m. PT. Gregory I. Frost, President and Chief Executive Officer, Halozyme Therapeutics, will provide a corporate overview.

(Logo: http://photos.prnewswire.com/prnh/20100302/LA63139LOGO)

The presentation will be webcast through the "Investors" section of Halozyme's corporate website at www.halozyme.com, and a recording will be made available for 90 days following the event. To access the live webcast, please log on to Halozyme's website approximately 15 minutes prior to the presentation to register and download any necessary audio software.

About Halozyme
Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. With a diversified portfolio of enzymes that target the extracellular matrix, the company's research focuses primarily on a family of human enzymes, known as hyaluronidases, which increase the absorption and dispersion of biologics, drugs and fluids. Halozyme's pipeline addresses therapeutic areas, including diabetes, oncology and dermatology that have significant unmet medical need. The company markets Hylenex® recombinant (hyaluronidase human injection) and has partnerships with Roche, Pfizer, Baxter, and Intrexon. Halozyme is headquartered in San Diego, CA. For more information on how we are innovating, please visit our corporate website at www.halozyme.com.<
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Halozyme to Present New Data on PEGPH20 in Pancreatic Cancer at European Cancer Congress
2. Halozyme Announces Roche Receives Marketing Authorization for Herceptin SC in European Union
3. Halozyme Reports Second Quarter 2013 Financial Results
4. Halozyme Provides Update on ViroPharma Phase 2 Trial of Subcutaneous Cinryze (C1 Esterase Inhibitor [Human]) Formulation with rHuPH20
5. Halozyme to Host Second Quarter 2013 Financial Results Conference Call
6. Halozymes Phase 1b Clinical Trial Of PEGPH20 With Gemcitabine Indicates Positive Activity Against Pancreatic Cancer
7. Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer
8. Halozyme Reports First Quarter 2013 Financial Results
9. Halozyme Therapeutics To Present At The Bank Of America Merrill Lynch 2013 Health Care Conference
10. Halozyme Therapeutics Names Matt Posard to Board of Directors
11. Baxter And Halozyme Announce Positive Opinion For HyQvia For Treatment Of Primary And Secondary Immunodeficiencies In The European Union
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 Zimmer Holdings, Inc. (NYSE ... fixation system for trauma patients. Available in ... ® External Fixation System from Zimmer is a ... materials.   The XtraFix System allows surgeons ... the external fixation process, resulting in saved time, costs and ...
(Date:3/27/2015)...  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) ... announced registered offering of common shares in ... the Offering, the Company issued 7,286,432 common shares at ... proceeds of approximately $1.45 billion. On March 18, 2015, ... Commission a final prospectus supplement to its effective shelf ...
(Date:3/27/2015)... , March 27, 2015   Hospira, Inc. ... in biosimilars and the world,s leading provider of ... that support an evaluation of biosimilarity of its ... and Drug Administration (FDA) conditionally approved name of ... (epoetin alfa). These study data were presented at ...
Breaking Medicine Technology:Zimmer Debuts New Modular External Fixation System 2Zimmer Debuts New Modular External Fixation System 3Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3
... 15, 2011 Now, with your own personal Breast Angel ... going to be able to actually see inside your breasts. ... what your normal internal physiological appearance is, and more importantly, ... to be a dreaded procedure nor a confusing one. Interpreting ...
... PALO ALTO, Calif., Feb. 15, 2011 Nfocus Neuromedical, ... on the next generation treatment for brain aneurysms, announced ... CE Mark for the treatment of patients with brain ... single-deployment, easy-to-use system for the treatment of brain aneurysms ...
Cached Medicine Technology:Breast Enlightenment Presents Breast Angel, the First Home Care Breast Health System, to Prevent Breast Cancer 2Nfocus Neuromedical, Inc. Luna™ Aneurysm Embolization System Receives CE Mark 2
(Date:3/28/2015)... NV (PRWEB) March 28, 2015 How ... is a growing field in orthopaedic medicine. While diagnostic ... tear to confirm the pain etiology, research presented today ... AOSSM ) Specialty Day suggests that pain relief from ... arthroscopic hip surgery. , “Our study looked to ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Early surgery ... with Type V AC joint injuries, according to new ... today at the American Orthopaedic Society for Sports Medicine’s ... to duty faster when surgery was not performed. , ... 7 receiving surgical treatment and 17 receiving non-surgical therapy. ...
(Date:3/28/2015)... 28, 2015 Andrew Hawley of Vintage Rock ... psychedelic concert posters. The Who and the Doors played together ... 2, 1968. According to Hawley, “The Who toured the United ... and college campuses. Perhaps the most famous Who poster was ... and the Doors on August 2, 1968 at the Singer ...
(Date:3/28/2015)... Aureus Medical Group (web: aureusmedical.com), a ... jobs, has announced that it will participate as ... Annual Conference to be held April 10-11, 2015 ... OH. , The OPTA Annual Conference offers ... and services. , Representatives from Aureus Medical’s ...
(Date:3/28/2015)... NV (PRWEB) March 28, 2015 ... new method of sustainable health. After 18 years of ... life, including professional UFC contenders, Dr. Jon Petrick is ... summer. , Just some of the immediate benefits of ... and vitality, increased levels of strength of the immune ...
Breaking Medicine News(10 mins):Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2Health News:For Type V AC Joint Injuries, Early Surgery May Not Be the Best Approach 2Health News:Avid Collector from Vintage Rock Posters, Inc. Announces His Search For&nbsp;Original 1960's Who Psychedelic Concert Posters. 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2Health News:Celebrity Chiropractor Jon Petrick to Release Sustainable Health System this Summer 2
... Jewish Health has received a grant for $950,308 from ... San Luis Valley with educational materials for patients and ... the most common chronic illness in children and adults, ... The San Luis Valley has one of the highest ...
... his State of the State announcement of a tenfold ... Kasich joined medical researchers from across the state on ... the faster network speeds will help enhance innovation. ... Medical Center, Case Western Reserve University School of Medicine, ...
... Mann HealthDay Reporter , MONDAY, Feb. 27 (HealthDay ... much needed rest at night, but using them routinely might ... develop certain types of cancer, research suggests. A new ... times more likely to die than people who don,t take ...
... is studying the differences between the social impairments found ... for people with both disorders. Autism spectrum disorder ... but they share similarities in social dysfunction. For many ... young people with ASD were thought to have a ...
... heart disease may not be able to compensate for their ... to Penn State researchers, making snow shoveling and other activities ... why cold air is such a trigger for coronary events," ... of the Heart and Vascular Institute, Penn State College of ...
... EAST LANSING, Mich. Often faced with overwhelming anxiety, patients ... and new research recommends nurses play a key role in ... patients. A diagnosis of lung cancer the leading ... with it high levels of stress and raises existential issues ...
Cached Medicine News:Health News:National Jewish Health receives grant to improve care of asthma patients in the San Luis Valley 2Health News:National Jewish Health receives grant to improve care of asthma patients in the San Luis Valley 3Health News:Kasich, doctors highlight the future of OARnet -- Ohio's Academic Research Network 2Health News:Kasich, doctors highlight the future of OARnet -- Ohio's Academic Research Network 3Health News:Sleeping Pills Linked to Raised Risk of Death, Cancer: Study 2Health News:Sleeping Pills Linked to Raised Risk of Death, Cancer: Study 3Health News:Study compares traits of autism, schizophrenia 2Health News:Cold air chills heart's oxygen supply 2Health News:Nurses key in helping new cancer patients overcome fears 2
... S600 ranks among Zebra's most popular printers. ... count on consistent, reliable performance. The S600 ... and Zebra Printer Management for real-time connectivity ... full-sized roll of media within the printer, ...
... High Performance line, Zebra's 110XiIIIPlus is a true ... printer is the one to call on for ... with either 4.09 inch (104 mm) or 3.2 ... best meets your needs, either 200, 300, or ...
... printing, the H 2824-Z direct thermal barcode ... improved patient safety and privacy. Generating clear ... variety of wristband types, the H 2824-Z ... on demand. It can also print bar ...
... The industrys first 600 dpi printer ... large amounts of bar code, text ... space. This printer is ideal for ... electronic components, telecommunication assemblies, computer peripherals, ...
Medicine Products: